GI Side Effects Across GLP-1 Drugs: What the Labels Say
Nausea, vomiting, diarrhea, and constipation show up on nearly every GLP-1 drug label. Here's how they're described and what tends to help.
By the GLP Semaglutide editorial team · Last updated February 1, 2026
Gastrointestinal side effects are the most commonly reported adverse events across GLP-1 receptor agonist labels, generally most pronounced during dose increases and tending to lessen once a patient has been at a stable dose for a while.
What labels commonly suggest
Product labeling and clinician guidance often point to eating smaller meals, avoiding high-fat foods, and staying hydrated during dose escalation, alongside slowing the titration pace if side effects are hard to tolerate.
When it's more than routine nausea
Severe abdominal pain, persistent vomiting, or symptoms of pancreatitis or gallbladder problems (which carry their own warnings on GLP-1 labels) warrant contacting a prescriber promptly rather than waiting it out.
Primary sources